Powered by
-
SHPG Stock Chart
Historical SHPG Prices
SHIRE SP ADR Stock Analysis
Rating: Hold
Total Grade: C
Analysis Breakdown
| SHPG Stock Grade: | C |
| Fundamental Grade: | B |
| Quantitative Grade: | D |
| SHPG Earnings | |
| Earnings Growth: | A |
| Earnings Momentum: | D |
| Earnings Surprises: | C |
| Analyst Earnings Revisions: | D |
| SHPG Financial Information | |
| Sales Growth: | B |
| Operating Margin Growth: | A |
| Cash Flow: | B |
| Return on Equity: | B |
SHIRE SP ADR Stock: Weekly View
| This Week: | C |
|---|---|
| Last Week: | D |
| Two Weeks Ago: | C |
SHPG Stock predictions, Articles, and SHIRE SP ADR News
- From InvestorPlace
- From the Web
-
The 7 Most Undervalued Stocks In Larry Robbins’ Portfolio - March 28, 2018
Larry Robbins is a well-known GARP investor. Here are some of his hedge fund's -- Glenview Capital Management -- most undervalued stocks. Continue…
-
Shire (SHPG) a Sell on Sagging Quant Score - December 11, 2017
Currently, Shire plc (NASDAQ:SHPG) has a Sell using Louis Navellier's investing methodology and his Portfolio Grader stock evaluator. SHPG has maintained this ranking for 11 months. Continue…
-
Lousy Quant Score Make Shire (SHPG) a Sell - December 4, 2017
Shire plc (NASDAQ:SHPG) is a constituent of the 350 company Biotechnology GICS industry group, which is part of the 782 company GICS Health Care sector. SHPG's market value is $44.8 billion which places it in the top 10% of its industry group. The current Portfolio Grader ranking for SHPG puts it 233 among the 350 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 538 among the 782 companies in the sector, and number 3,229 in the nearly 5,000 company Portfolio Grader universe. Continue…
-
8 Most Undervalued Stocks Fund Managers Are Buying - November 28, 2017
One of the better-kept secrets in investing is a form called the 13F-HR that all institutional investors who manage over $100 million in assets must.... Continue…
-
Shire (SHPG) a Sell on Flopping Industry Group Rank - November 27, 2017
With a $44.7 billion market value, Shire plc (NASDAQ:SHPG) ranks in the top decile in its industry group, Biotechnology, and in the top 10% of its sector group, Health Care, in market value. From the vantage point of investment attractiveness, the ranking for SHPG by Portfolio Grader places it 216 among the 349 companies in this industry group, giving it a lower than average position; in the third quartile of the sector with a ranking of 521 among the 781 companies in the sector, and number 3,243 in the nearly 5,000 company Portfolio Grader universe. Continue…
-
Earnings Growth Make Shire (SHPG) a Sell - November 20, 2017
Currently, Shire plc (NASDAQ:SHPG) has a Sell using Louis Navellier's investing system and his Portfolio Grader stock evaluator. SHPG has maintained this ranking for 11 months. Continue…
-
Analytics for Industry Group Rank Make Shire (SHPG) a Sell - November 13, 2017
Currently, Shire plc (NASDAQ:SHPG) has a Sell using Louis Navellier's approach to investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking SHPG has had from Portfolio Grader for 11 months. Continue…
-
Analytics for Earnings Growth Make Shire (SHPG) a Sell - November 6, 2017
Currently, Shire plc (NASDAQ:SHPG) has a Sell using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. SHPG has maintained this ranking for 11 months. Continue…
-
Falling Earnings Visibility Keeps Shire (SHPG) a Sell - October 30, 2017
Shire plc (NASDAQ:SHPG) is one of 347 companies within the Biotechnology GICS industry group, which is in turn part of the 783 company GICS Health Care sector. SHPG's market value is $43.0 billion which places it in the top 10% of its industry group. The current Portfolio Grader ranking for SHPG puts it 242 among the 347 companies in this industry group, which is a below-average position; in the third quartile of the sector with a ranking of 564 among the 783 companies in the sector, and number 3,660 in the nearly 5,000 company Portfolio Grader universe. Continue…
-
Shire (SHPG) a Sell on Falling Quant Score - October 23, 2017
Portfolio Grader currently ranks Shire plc (NASDAQ:SHPG) a Sell. The system for investing incorporated in this analytical tool developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking SHPG has had from Portfolio Grader for 11 months. Continue…
